The effect of zoledronic acid on the clinical resolution of charcot neuroarthropathy: A pilot randomized controlled trial

Diabetes Care

Volumn 34, Issue 7, 2011, Pages 1514-1516

  Pakarinen, Toni Karri ^a   Laine, Heikki Jussi ^a   Maënpä̈a, Heikki ^a,b   Mattila, Pentti ^a   Lahtela, Jorma ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMOBILIZATION; MALE; NEUROPATHIC JOINT DISEASE; ORTHOSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; FOOT DISEASE; MIDDLE AGED; PILOT STUDY;

ADULT; ARTHROPATHY, NEUROGENIC; DIABETIC NEUROPATHIES; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FEMALE; FOOT DISEASES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 80054704617     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0396     Document Type: Article

References (14)

1. Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000;23:796-800 (Pubitemid 30414196)
2. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26:1435-1438 (Pubitemid 36929175)
3. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005;366:2058-2061 (Pubitemid 41773381)
4. Baumhauer JF, O'Keefe RJ, Schon LC, Pinzur MS. Cytokine-induced osteoclastic bone resorption in charcot arthropathy: an immunohistochemical study. Foot Ankle Int 2006;27:797-800 (Pubitemid 44497847)
5. Jacobs JE. Observations of neuropathic (Charcot) joints occurring in diabetes mellitus. J Bone Joint Surg Am 1958;40-A:1043-1057
6. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994;11:28-31 (Pubitemid 24040538)
7. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001;44:2032-2037 (Pubitemid 33124049)
8. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 2004;43:285-289 (Pubitemid 39335777)
9. Pitocco D, Ruotolo V, Caputo S, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 2005;28:1214-1215 (Pubitemid 40616640)
10. Bem R, Jirkovská A, Fejfarová V, Skibová J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 2006;29:1392-1394 (Pubitemid 44125943)
11. Tan PL, Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol 2007;80:939-948 (Pubitemid 350206225)
12. Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med 2005;22:1707-1712 (Pubitemid 43046472)
13. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997;14:357-363 (Pubitemid 27248015)
14. Tan AL, Greenstein A, Jarrett SJ, McGonagle D. Acute neuropathic joint disease: a medical emergency? Diabetes Care 2005;28:2962-2964 (Pubitemid 43942932)